Article
BIRC5 expression is a poor prognostic marker in Ewing sarcoma
7 Sept 2012
Abstract excerpt
BACKGROUND: BIRC5 (Survivin), an inhibitor of apoptosis protein (IAP), is over-expressed in several human cancers and increased expression is associated with poor prognosis. The goal of the current study was to evaluate the role of BIRC5 in Ewing sarcoma (ES), the second most common pediatric bone sarcoma. PROCEDURE: BIRC5 protein expression was determined in ES cell lines using Western Blot analysis. Functional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
